Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it received certification from the National Committee for Quality Assurance (“NCQA”) Healthcare Effectiveness Data and Information Set (“HEDIS®”) Health Plan Measure Certification Program™. It is the second year in which the Company has received this certification, and in measurement year 2023, ApolloMed expanded its certification from 5 to 20 measures, covering the most widely used HEDIS measures in the managed care industry.
NCQA (www.ncqa.org) is an independent, non-profit organization that accredits and certifies a wide range of healthcare organizations and manages the evolution of HEDIS, the healthcare quality measurement tool used by more than 90 percent of health plans in the United States, covering 200 million people.
This certification allows ApolloMed to provide services that align with the industry’s most rigorous clinical quality measurement processes, resulting in more accurate and timely identification of eligible members and services. ApolloMed designed and implemented its HEDIS engine as a RESTful API to work in an interoperable way with other data engines and technologies, increasing the measure outputs’ transparency, interpretability, and usability.
In 2023, ApolloMed was certified by the NCQA HEDIS Health Plan Measure Certification Program™ for 20 different measures. This year’s certified measures include key diabetes measures, such as Hemoglobin A1c Control for Patients with Diabetes (HBD), Blood Pressure Control for Patients with Diabetes (BPD), Eye Exam for Patients with Diabetes (EED), Kidney Health Evaluation for Patients with Diabetes (KED), and 16 other measures.
HEDIS® is a registered trademark of NCQA. NCQA HEDIS Health Plan Measure Certification Program™ is a trademark of NCQA.